Osteopore Ltd
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates spe… Read more
Osteopore Ltd (OSX) - Total Assets
Latest total assets as of June 2025: AU$4.19 Million AUD
Based on the latest financial reports, Osteopore Ltd (OSX) holds total assets worth AU$4.19 Million AUD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Osteopore Ltd - Total Assets Trend (2016–2024)
This chart illustrates how Osteopore Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Osteopore Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Osteopore Ltd's total assets of AU$4.19 Million consist of 75.0% current assets and 25.0% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 20.4% |
| Accounts Receivable | AU$1.07 Million | 34.1% |
| Inventory | AU$379.51K | 12.1% |
| Property, Plant & Equipment | AU$322.51K | 10.3% |
| Intangible Assets | AU$461.86K | 14.7% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Osteopore Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Osteopore Ltd's current assets represent 75.0% of total assets in 2024, a decrease from 75.6% in 2016.
- Cash Position: Cash and equivalents constituted 20.4% of total assets in 2024, up from 3.4% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 34.1% of total assets.
Osteopore Ltd Competitors by Total Assets
Key competitors of Osteopore Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Osteopore Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Osteopore Ltd generates 0.90x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Osteopore Ltd is currently not profitable relative to its asset base.
Osteopore Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.22 | 1.36 | 2.36 |
| Quick Ratio | 1.11 | 1.25 | 2.31 |
| Cash Ratio | 0.59 | 0.81 | 0.00 |
| Working Capital | AU$663.50K | AU$ 994.07K | AU$ 1.78 Million |
Osteopore Ltd - Advanced Valuation Insights
This section examines the relationship between Osteopore Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 15.36 |
| Latest Market Cap to Assets Ratio | 0.24 |
| Asset Growth Rate (YoY) | -6.2% |
| Total Assets | AU$3.13 Million |
| Market Capitalization | $740.73K USD |
Valuation Analysis
Below Book Valuation: The market values Osteopore Ltd's assets below their book value (0.24 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Osteopore Ltd's assets decreased by 6.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Osteopore Ltd (2016–2024)
The table below shows the annual total assets of Osteopore Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | AU$3.13 Million | -6.23% |
| 2023-12-31 | AU$3.34 Million | -7.66% |
| 2022-12-31 | AU$3.62 Million | -39.72% |
| 2021-12-31 | AU$6.01 Million | -41.39% |
| 2020-12-31 | AU$10.25 Million | +139.16% |
| 2019-12-31 | AU$4.28 Million | -20.68% |
| 2018-12-31 | AU$5.40 Million | +1445.09% |
| 2017-12-31 | AU$349.61K | -59.29% |
| 2016-12-31 | AU$858.80K | -- |